Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2025)

Universe Pharmaceuticals (UPC) has disclosed Total Liabilities for 6 consecutive years, with $13.2 billion as the latest value for Q3 2025.

  • Quarterly Total Liabilities fell 41.32% to $13.2 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 billion through Sep 2025, down 41.32% year-over-year, with the annual reading at $13.2 billion for FY2025, 41.32% down from the prior year.
  • Total Liabilities hit $13.2 billion in Q3 2025 for Universe Pharmaceuticals, down from $22.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $22.5 billion in Q3 2024 to a low of -$35.3 billion in Q3 2022.
  • Historically, Total Liabilities has averaged $78.1 million across 5 years, with a median of $23.2 million in 2021.
  • Biggest five-year swings in Total Liabilities: plummeted 152442.21% in 2022 and later soared 163124.63% in 2024.
  • Year by year, Total Liabilities stood at $23.2 million in 2021, then tumbled by 152442.21% to -$35.3 billion in 2022, then soared by 100.04% to $13.8 million in 2023, then skyrocketed by 163124.63% to $22.5 billion in 2024, then tumbled by 41.32% to $13.2 billion in 2025.
  • Business Quant data shows Total Liabilities for UPC at $13.2 billion in Q3 2025, $22.5 billion in Q3 2024, and $13.8 million in Q3 2023.